#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13354	16S	1529	1529	100.0	16S.l6.c17.ctg.1	1991	663.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1394	1394	C	825	C	774	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13354	16S	1529	1529	100.0	16S.l6.c17.ctg.1	1991	663.2	0	HET	.	.	.	C226T	.	226	226	C	436	436	C	700	C,T	518,136	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23674	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3498	674.3	0	.	n	.	0	T695C	SNP	695	695	T	1014	1014	C	720	C,T	674,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23674	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3498	674.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	1957	1957	G	746	G,A	532,177	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23674	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3498	674.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2290	2290	C	787	C	743	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23674	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3498	674.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2364	2364	A	791	A	749	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23674	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3498	674.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2916	2916	C	757	C	723	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23674	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3498	674.3	0	HET	.	.	.	C539T,A	.	539	539	C	858	858	C	747	C,T,A	527,177,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1932	folP	855	855	100.0	folP.l6.c30.ctg.1	1615	119.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1106	1108	AGC	205;202;197	A;G;C	191;189;185	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5124	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3417	149.4	1	SNP	p	S91F	1	.	.	271	273	TTC	533	535	TTC	171;172;172	T;T;C	156;157;156	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5124	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3417	149.4	1	SNP	p	G95N	0	.	.	283	285	GGC	545	547	GGC	174;174;171	G;G;C	159;156;154	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5124	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3417	149.4	1	SNP	p	D95G	1	.	.	283	285	GGC	545	547	GGC	174;174;171	G;G;C	159;156;154	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1482	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1486	99.4	1	SNP	p	G45D	0	.	.	133	135	GGC	601	603	GGC	169;172;175	G;G;C	162;164;167	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	812	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	880	91.2	0	.	n	.	0	A197.	DEL	197	197	A	525	525	A	192	A	181	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4804	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2962	161.3	1	SNP	p	D86N	0	.	.	256	258	GAC	601	603	GAC	212;215;214	G;A;C	192;192;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4804	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2962	161.3	1	SNP	p	R87I	0	.	.	259	261	CGT	604	606	CGT	211;212;211	C;G;T	193;192;190	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4804	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2962	161.3	1	SNP	p	S87R	1	.	.	259	261	CGT	604	606	CGT	211;212;211	C;G;T	193;192;190	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4804	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2962	161.3	1	SNP	p	R87W	0	.	.	259	261	CGT	604	606	CGT	211;212;211	C;G;T	193;192;190	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4804	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2962	161.3	1	SNP	p	S88P	0	.	.	262	264	TCC	607	609	TCC	209;211;209	T,A;C;C	186,1;192;191	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4120	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2642	155.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1523	1525	GGC	184;181;179	G;G;C	169;168;167	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1312	1314	GCA	213;216;213	G;C;A	197;198;198	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1315	1317	ATC	208;208;216	A;T;C	195;195;200	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1327	1329	GTG	221;224;226	G;T;G	204;204;205	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1327	1329	GTG	221;224;226	G;T;G	204;204;205	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1831	1833	ACC	202;198;199	A;C;C	176;181;180	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1885	1887	GCG	189;189;190	G;C;G	165;154;159	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1885	1887	GCG	189;189;190	G;C;G	165;154;159	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2008	2010	AGC	161;158;159	A,G;G;C	145,1;144;145	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2017	2019	GGC	152;154;153	G;G;C	140;143;142	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3698	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2454	150.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2035	2037	CCG	126;128;128	C,G;C;G	91,2;96;95	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5090	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3017	167.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1618	1620	CCG	194;195;191	C;C;G	171;177;170	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1952	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1741	111.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	460	460	C	157	C	147	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	479	30.2	0	.	p	.	0	M18T	NONSYN	52	54	ATG	332	334	ACG	68;67;66	A;C;G	62;63;61	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	479	30.2	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	374	376	CAA	33;30;27	C;A;A	31;28;25	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	296	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	479	30.2	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	380	382	TAC	19;18;16	T;A;C	17;17;15	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2548	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1514	167.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	440	442	GAA	222;220;220	G;A;A	210;207;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2548	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1514	167.2	0	.	p	.	0	K41D	NONSYN	121	123	AAA	449	451	GAC	221;220;220	G;A;C	205;202;206	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2548	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1514	167.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	851	853	TCA	209;207;210	T;C;A	195;194;194	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2548	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1514	167.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	980	982	GTC	184;183;184	G;T;C	171;171;174	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2548	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1514	167.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	992	994	TCT	187;186;189	T;C;T	176;175;177	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2548	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1514	167.2	0	.	p	.	0	A272V	NONSYN	814	816	GCG	1142	1144	GTG	241;242;240	G;T,A;G	215;217,1;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2548	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1514	167.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1310	1312	GCA	201;201;200	G;C;A	190;189;186	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9538	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4731	200.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1084	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1130	95.5	1	SNP	p	V57M	1	.	.	169	171	ATG	558	560	ATG	226;226;231	A;T;G	215;215;216	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
